Obsessive-Compulsive Disorder – Epidemiology – Europe
Clarivate Epidemiology’s coverage of obsessive-compulsive disorder (OCD) comprises epidemiological estimates of key patient populations in the European countries (Austria, Belgium, Czech Republic, Denmark, Finland, Greece, Netherlands, Norway, Poland, Portugal, Sweden and Switzerland). We report the total 12-month prevalence and the severity of OCD for each country, as well as annualized case counts projected to the national population.
Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets and 10 years for the remaining countries covered in this report.
Clarivate Epidemiology’s OCD forecast will answer the following questions:
- How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of OCD over the forecast period?
All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is provided for full transparency into research and methods.
Clarivate Epidemiology provides at least 10 years of forecast data for the following OCD patient populations:
- Total 12-month prevalent cases.
- Total 12-month prevalent cases by severity—mild, moderate, severe.
Note: Coverage may vary by country and region.
Table of contents
- Obsessive-Compulsive Disorder - Epidemiology - Europe
- Epidemiology data
- Methods
- Literature review (studies included in/excluded from the analyses of obsessive-compulsive disorder)
- Total OCD 12-month prevalent cases
- Total OCD 12-month prevalent cases by severity
- Risk / protective factors applied to disease forecast models
- Reference materials
- Bibliography
- Glossary
- Abbreviation Table
Mariam Sophia, B.D.S., M.P.H., is an associate epidemiologist at Clarivate. Prior to studying epidemiology, she worked in a private clinical practice and later as a tutor at Manipal College of Dental Sciences. She has experience working in COVID-19 care centers and in Tele ICU. She holds an M.P.H. from India’s Manipal University, where she specialized in epidemiology, and a B.D.S. from India’s Yenepoya University. Her research thesis assessed the nutritional status of tribal children less than five years old. She was also an intern in the government-run tuberculosis program (RNTCP).
Mudasir Khan, M.P.H., is a senior epidemiologist at Clarivate. His areas of expertise are oncology and psychiatry. He holds a master’s degree in public health from the Tata Institute of Social Sciences in Mumbai.